Month: February 2018

Snippet: M&A activities of big pharma’s will fuel CAR-T cell therapy

Business Consultant, Pharma Consultant, Snippets

Gilead Sciences Inc. bought Kite Pharma (USD 11.9 Billion) while Celgene took over Juno Therapeutics (USD 9 Billion) to make the greatest...

Read More

The Business Cocktail : Latest Pharma deals

Business Consultant, Pharma Consultant, The Business Cocktail

Ionis pharmaceuticals recently licensed-out its antisense drug to AstraZeneca in deal total worth up to USD 330 million Ionis...

Read More

Notizia

Notizia

Read More

Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets

Articles, Business Consultant, Pharma Consultant

Immune checkpoints are the regulators of immune activation. They play a key role in maintaining immune homeostasis and preventing...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Vertex pharmaceutical’s growth story in biotech with Symdeko’s approval FDA has recently approved Vertex Pharmaceutical’s latest...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Roivant expanding its horizon into metabolic diseases segment with USD 650 million diabetes pact with Poxel Roivant Sciences has recently...

Read More

Natural Killer Cell Therapies: An Emerging Cellular Therapy

Articles, Business Consultant, Pharma Consultant

Natural killer cells are the innate immune cells that are naturally involved in tumor immunosurveillance. These cells have direct cytotoxic...

Read More
Close